SHPK and chronic myelogenous leukemia, BCR-ABL1 positive: SHK could suppress the proliferation and migration of CML K562 leukemia cells and induce apoptosis by increasing PTEN level and inactivated PI3K/AKT signaling pathway (Chen et al., 2018).